752
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Sunflower seed extract enhances the differentiation of osteoblastic MC3T3-E1 cells

Pages 9-19 | Received 24 Nov 2011, Accepted 25 Jul 2012, Published online: 28 Aug 2012

References

  • Atkinson, A.S., & Ward, E.W. (2001). Clinical nutrition: 2. The role of nutrition in the prevention and treatment of adult osteoporosis. Canadian Medical Association Journal, 165, 1511–1514.
  • Bau, H.M., Mohtadi-Nia, D.J., & Mejean, L.G. (1983). Preparation of colorless sunflower protein products: Effect of processing on physicochemical and nutritional properties. Journal of the American Oil Chemists' Society, 60, 1141–1147.
  • Bellows, C.G., Aubin, J.E., & Heersche, J.N.M. (1991). Initiation and progression of mineralization of bone nodules formed in vitro: The role of alkaline phosphatase and organic phosphate. Bone and Mineral, 14, 27–40.
  • Boue, S.M., Wiese, T.E., Nehls, S., Burow, M.E., Elliott, S., Carter-Wientjes, C.H., et al. (2003). Evaluation of the estrogenic effects of legume extracts containing phytoestrogens. Journal of Agricultural and Food Chemistry, 51, 2193–2199.
  • Choi, E.M. (2005). The licorice root derived isoflavan glabridin increases the function of osteoblastic MC3T3-E1 cells. Biochemical Pharmacology, 70, 363–368.
  • Choi, E.M., & Kim, Y.H. (2008). Hesperetin attenuates the highly reducing sugar-triggered inhibition of osteoblast differentiation. Cell Biology and Toxicology, 24, 225–231.
  • Fuller, K., Gallagher, A.C., & Chambers, T.J. (1991). Osteoclast resorption stimulating activity is associated with the osteoblast cell surface and/or the extracellular matris. Biochemical and Biophysical Research Communications, 181, 67–73.
  • Girasole, G., Jilka, R.L, Passeri, G., Boswell, S., Boder, G., Williams, D.C., et al. (1992). 17-β oestradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens. Journal of Clinical Investigation, 89, 883–891.
  • Ishii, T., Saito, T., Morimoto, K., Takeuchi, Y., Asano, S., Kumegawa, M., et al. (1993). Estrogen stimulates the elaboration of cell/matrix surface-associated inhibitory factor of osteoclastic bone resorption from osteoblastic cells. Biochemical and Biophysical Research Communications, 191, 495–502.
  • Kris-Etherton, M.P., Hecker, K.D., Bonanome, A., Coval, S.M., Binkoski, A.E., Hilpert, K.F., et al (2002). Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer. American Journal of Medicine, 113, 71S–88S.
  • Lee, K.H., & Choi, E.M. (2008). Myricetin, a naturally occurring flavonoid, prevents 2-deoxy-D-ribose induced dysfunction and oxidative damage in osteoblastic MC3T3-E1 cells. European Journal of Pharmacology, 591, 1–6.
  • Leung, J., Fenton, T.W., & Clandinin, D.R. (1981). Phenolic compounds of sunflower flour. Journal of Food Science, 46, 1386–1393.
  • Ma, H.P., Ming, L.G., Ge, B.F., Zhai, Y.K., Song, P., Xian, C.J., et al. (2011). Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro. Journal of Cellular Biochemistry, 112, 916–923.
  • Macias, F.A., López, A., Varela, R.M., Torres, A., & Molinillo, J.M. (2004). Bioactive lignans from a cultivar of Helianthus annuus. Journal of Agricultural and Food Chemistry, 52, 6443–6447.
  • Newton, K.M., & Grady, D. (2011). Soy isoflavones for prevention of menopausal bone loss and vasomotor symptoms: Comment on “Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms”. Archives of Internal Medicine, 171, 1369–1370.
  • Pfister, A.K., Welch, C.A., Lester, M.D., Emmett, M.K., Saville, P.D., & Duerring, S.A. (2006). Cost-effectiveness strategies to treat osteoporosis in elderly women. Southern Medical Journal, 99, 123–131.
  • Quarles, L.D., Yohay, D.A., Lever, L.W., Caton, R., & Wenstrup, R.J. (1992). Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: An in vitro model of osteoblast development. Journal of Bone and Mineral Research, 7, 683–690.
  • Rios, J.L., Giner, R.M., & Prieto, J.M. (2002). New findings on bioactivity of lignans. Studies in Natural Products Chemistry, 26, 183–292.
  • Rodan, G.A., & Martin, T.J. (2000). Therapeutic approaches to bone diseases. Science, 289, 1508–1514.
  • Ward, R.S. (1999). Lignans, neolignans and related compounds. Natural Product Reports, 16, 75–96.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.